Procurement Summary
Country: Brazil
Summary: Acquisition of Injectable Medications.
Deadline: 26 Feb 2026
Posting Date: 12 Feb 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 135660737
Document Ref. No.: 91007/2026
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of injectable medicines. UASG code: 925162 Notice from: 02/12/2026 from 08:00 to 12:50 and from 13:00 to 17:59 Proposal Delivery: from 02/12/2026 at 08:00 ACETYLCYSTEINE, DOSAGE 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 8600 ACICLOVIR, DOSAGE 250 MG, INJECTABLE USE Quantity: 30000 AMINOCAPROIC ACID, DOSAGE 50 MG/ML, INJECTABLE SOLUTION INDICATIONS Quantity: 1500 AMINOCAPROIC ACID, DOSAGE 200 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 1000 ÁCIDO ASCÓRBICO, DOSAGEM 100 MG/ML, TIPO USO INJETÁVEL Quantity: 100000 TRANEXAMIC ACID, DOSAGE 50 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 50000 ADENOSINA, DOSAGEM 3 MG/ML, INDICAÇÃO SOLUÇÃO INJECTABLE Quantity: 19200 HUMAN ALBUMIN, 20% CONCENTRATION, INJECTABLE USE Quantity: 1500 AMIODARONE, DOSAGE 50MG/ML, INJECTABLE INDICATION Quantity: 72000 ATRACURIUM BESYLATE, DOSAGE 10 MG/ML, INJECTABLE SOLUTION INDICATIONS Quantity: 6400 ATROPINE SULFATE, DOSAGE 0.25 MG/ML, USE INJECTABLE SOLUTION Quantity: 21000 ATROPINE SULFATE, DOSAGE 0.50 MG/ML, USE INJECTABLE SOLUTION Quantity: 1000 BETAMETHASONE, ACETATE COMPOSITION, PRESENTATION ASSOCIATED WITH BETAMETHASONE PHOSPHATE, DOSAGE 3MG + 3MG/ML, USE INJECTABLE Quantity: 20500 BROMOPRIDE, DOSAGE 5 MG/ML, INJECTABLE PRESENTATION Quantity: 110000 BUPIVACAINE HYCLORHYDRATE, PRESENTATION ASSOCIATED WITH GLUCOSE, DOSAGE 0.5% + 8%, INJECTABLE SOLUTION TYPE Quantity: 5800 KETOPROFEN, CONCENTRATION 50 MG/ML, FORM PHARMACEUTICA INJECTABLE SOLUTION Quantity: 100000 TROMETAMOL, KETOROLAC SALT COMPOSITION, CONCENTRATION 30 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 4320 CISATRACURIUM BESYLATE, CONCENTRATION 2 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity : 3500 CLONIDINE HYCLORHYDRATE, CONCENT...
Documents
Tender Notice